Literature DB >> 29635686

The anatomy and physiology of the terminal thoracic duct and ostial valve in health and disease: potential implications for intervention.

Chathura Bathiya Bandara Ratnayake1, Alistair Brian James Escott1, Anthony Ronald John Phillips1,2, John Albert Windsor1.   

Abstract

The thoracic duct (TD) transports lymph drained from the body to the venous system in the neck via the lymphovenous junction. There has been increased interest in the TD lymph (including gut lymph) because of its putative role in the promotion of systemic inflammation and organ dysfunction during acute and critical illness. Minimally invasive TD cannulation has recently been described as a potential method to access TD lymph for investigation. However, marked anatomical variability exists in the terminal segment and the physiology regarding the ostial valve and terminal TD is poorly understood. A systematic review was conducted using three databases from 1909 until May 2017. Human and animal studies were included and data from surgical, radiological and cadaveric studies were retrieved. Sixty-three articles from the last 108 years were included in the analysis. The terminal TD exists as a single duct in its terminal course in 72% of cases and 13% have multiple terminations: double (8.5%), triple (1.8%) and quadruple (2.2%). The ostial valve functions to regulate flow in relation to the respiratory cycle. The patency of this valve found at the lymphovenous junction opening, is determined by venous wall tension. During inspiration, central venous pressure (CVP) falls and the valve cusps collapse to allow antegrade flow of lymph into the vein. During early expiration when CVP and venous wall tension rises, the ostial valve leaflets cover the opening of the lymphovenous junction preventing antegrade lymph flow. During chronic disease states associated with an elevated mean CVP (e.g. in heart failure or cirrhosis), there is a limitation of flow across the lymphovenous junction. Although lymph production is increased in both heart failure and cirrhosis, TD lymph outflow across the lymphovenous junction is unable to compensate for this increase. In conclusion the terminal TD shows marked anatomical variability and TD lymph flow is controlled at the ostial valve, which responds to changes in CVP. This information is relevant to techniques for cannulating the TD, with the aid of minimally invasive methods and high resolution ultrasonography, to enable longitudinal physiology and lymph composition studies in awake patients with both acute and chronic disease.
© 2018 Anatomical Society.

Entities:  

Keywords:  lymphovenous junction; ostial valve; terminal thoracic duct; thoracic duct physiology

Mesh:

Year:  2018        PMID: 29635686      PMCID: PMC5987815          DOI: 10.1111/joa.12811

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  77 in total

1.  Thoracic duct and cisterna chyli: evaluation with multidetector row CT.

Authors:  M Kiyonaga; H Mori; S Matsumoto; Y Yamada; M Sai; F Okada
Journal:  Br J Radiol       Date:  2012-01-17       Impact factor: 3.039

2.  Normal CT appearance of the distal thoracic duct.

Authors:  Ming-Eng Liu; Barton F Branstetter; Joseph Whetstone; Edward J Escott
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

3.  Alterations in Thoracic Duct Lymph Flow in Hepatic Cirrhosis: Significance in Portal Hypertension.

Authors:  A E Dumont; J H Mulholland
Journal:  Ann Surg       Date:  1962-10       Impact factor: 12.969

Review 4.  Review of thoracic duct anatomical variations and clinical implications.

Authors:  K Phang; M Bowman; A Phillips; J Windsor
Journal:  Clin Anat       Date:  2013-12-02       Impact factor: 2.414

5.  Morphological and histological analysis of the thoracic duct at the jugulo-subclavian junction in Japanese cadavers.

Authors:  K Shimada; I Sato
Journal:  Clin Anat       Date:  1997       Impact factor: 2.414

6.  Radiology of the thoracic duct.

Authors:  A Rosenberger; H L Abrams
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-04

7.  Three-dimensional lymphoscintigraphy using SPECT/CT and 123I-BMIPP for the preoperative detection of anatomical anomalies of the thoracic duct.

Authors:  Kentaro Takanami; Hirofumi Ichikawa; Hiroshi Fukuda; Shoki Takahashi
Journal:  Clin Nucl Med       Date:  2012-11       Impact factor: 7.794

8.  The association of a retroesophageal right subclavian artery, a right-sided terminating thoracic duct, and a left vertebral artery of aortic origin: anatomical and clinical considerations.

Authors:  H Nathan; M R Seidel
Journal:  Acta Anat (Basel)       Date:  1983

9.  CT of the thoracic duct.

Authors:  P Schnyder; H Hauser; A Moss; G Gamsu; R Brasch; J Bohnet; G Candardjis
Journal:  Eur J Radiol       Date:  1983-02       Impact factor: 3.528

10.  Intrinsic propulsive activity of thoracic duct perfused in anesthetized dogs.

Authors:  N P Reddy; N C Staub
Journal:  Microvasc Res       Date:  1981-03       Impact factor: 3.514

View more
  5 in total

Review 1.  Establishment and maintenance of blood-lymph separation.

Authors:  Harish P Janardhan; Chinmay M Trivedi
Journal:  Cell Mol Life Sci       Date:  2019-02-13       Impact factor: 9.261

2.  Postmortem Retrograde Contrasted Infusion in Thoracic Duct Outflow: Imaging Effectiveness Analysis.

Authors:  Rogério Rodrigo Ramos; Mariane Gabriela Terezani; Elís Claudia Ribeiro Cantarella; Jose Maria Pereira de Godoy; Fernando Batigalia; Luciana Estevam Simonato; Wagner Rafael da Silva; José Martins Pinto Neto; André Wilian Lozano; Nilton Cesar Pezati Boer
Journal:  Cureus       Date:  2022-04-17

Review 3.  Mediators of Regional Kidney Perfusion during Surgical Pneumo-Peritoneum Creation and the Risk of Acute Kidney Injury-A Review of Basic Physiology.

Authors:  Csaba Kopitkó; László Medve; Tibor Gondos; Karim Magdy Mohamed Soliman; Tibor Fülöp
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

Review 4.  Recurrent thoracic duct cyst of the left supraclavicular fossa: A retrospective study of 6 observational case series and literature review.

Authors:  Julie Planchette; Clara Jaccard; Audrey Nigron; Jean-Baptiste Chadeyras; Guillaume Le Guenno; Benjamin Castagne; Yvan Jamilloux; Anne-Sophie Resseguier; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

Review 5.  The interstitial compartment as a therapeutic target in heart failure.

Authors:  Doron Aronson
Journal:  Front Cardiovasc Med       Date:  2022-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.